ALPHA CLINICAL DEVELOPMENTS LIMITEDActive
Key figures
Like most small UK companies, ALPHA CLINICAL DEVELOPMENTS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | — | — | — | — | — |
| Total assets | 233,213 | 1,367,015 | 1,380,848 | 1,454,957 | 1,290,445 |
| Total liabilities | 187,979 | 1,243,728 | 1,240,598 | 965,585 | 864,880 |
| Net assets / total equity | 45,234 | 123,287 | 140,250 | 489,372 | 425,565 |
| Average number of employees | 0 | 0 | 1 | 3 | 6 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: ALPHA CLINICAL DEVELOPMENTS LIMITED
Company
ALPHA CLINICAL DEVELOPMENTS LIMITED is a private limited company registered with Companies House under company number 08100223. It was incorporated on 11 Jun 2012. Its status is active. The registered office is in Salford (M3). Its nature of business (SIC 2007) is other research and experimental development on natural sciences and engineering (72190).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files micro-entity accounts. Net assets were £425,565, down 13% on the previous year. Total assets were £1,290,445 and total liabilities £864,880. The company had an average of 6 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 9 Oct 2026.